Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ESICON: Induction Chemotherapy for Olfactory Neuroblastoma
NCT06255210Phase 2Recruiting
- Start
- Mar 2024
- Primary completion
- Mar 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of gemcitabine, cisplatin, cyclophosphamide, etoposide in olfactory neuroblastoma (ONB). Started Mar 2024; status: recruiting.
02
Drugs
gemcitabinecisplatincyclophosphamideetoposide
03
Conditions
olfactory neuroblastoma (ONB)
Beyond the preview
Go deeper on NCT06255210.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06255210.